
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PERK CRISPR/Cas9 KO Plasmid (h2) | sc-400080-KO-2 | 20 µg | $397.00 | |||
PERK HDR Plasmid (h2) | sc-400080-HDR-2 | 20 µg | $445.00 |
EIF2AK3 encodes PERK, an ER-resident serine/threonine kinase that functions as a core sensor of the unfolded protein response. Upon ER stress, PERK phosphorylates eIF2α to attenuate global translation while promoting integrated stress response programs that shape redox balance, autophagy, and apoptotic signaling. PERK signaling interfaces with ATF4/CHOP transcriptional networks and coordinates proteostasis with mitochondrial function and metabolic adaptation. Dysregulated EIF2AK3/PERK activity has been implicated in disorders linked to chronic ER stress, including neurodegeneration, diabetes-related β-cell dysfunction, and tumor microenvironmental stress responses.
PERK CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the EIF2AK3 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the EIF2AK3 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, PERK HDR Plasmid (h2) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined EIF2AK3 target site.
When co-transfected with PERK CRISPR/Cas9 KO Plasmid (h2):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the EIF2AK3 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.